Hydroxyzine Pamoate
- Product NDC
- 68071-2573
- 11-digit product format
- 680712573
- Labeler code
- 68071
- Product ID
- 68071-2573_d0d91cc2-ef07-d019-e053-2a95a90aa365
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Pamoate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA040156
- Marketing category
- ANDA
- Marketing start
- 1996-07-15
- Marketing end
- 0000-00-00
- Substance
- HYDROXYZINE PAMOATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC],Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| M20215MUFR | HYDROXYZINE PAMOATE | 10246-75-0 | HYDROXYZINE PAMOATE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2573-1 | 68071257301 | 100 CAPSULE in 1 BOTTLE, PLASTIC (68071-2573-1) | 100 capsule | 2021-11-15 | 0000-00-00 | No | No | Current |